90389413 - THROMBO INCODE

Information

• Trademark
• 90389413

• Source

• Serial Number

  90389413

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  December 17, 2020
  4 years ago

• Transaction Date

  April 10, 2023
  a year ago

• Status Date

  April 10, 2023
  a year ago

• Published for Opposition Date

  July 12, 2022
  2 years ago

• Location Date

  September 06, 2022
  2 years ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  FICKES, JERI J

• Attorney Docket Number

  S25166

  Attorney Name

  LEIGH ANN LINDQUIST

  Law Office Assigned Location Code

  L70

• Owners

  • GENINCODE UK LIMITED

Case File Statements

• GS0051: medical diagnostic reagents; genetic identity tests comprised of reagents for medical purposes; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease risk assessment, namely, thrombotic diseases and other related coagulation or anti-coagulation based diseases
• PM0001: THROMBO IN CODE
• GS0441: medical services; diagnostic services, including testing, consulting services and reporting in the fields of medical diagnostics and disease risk assessment; genetic testing for medical purposes; medical diagnostic testing, monitoring and reporting services; providing disease profiles and medical data analysis and risk assessments via an online digital portal designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptoms and concerns; consultation in the field of health risk assessment, namely, health counseling, genetic counseling
• D10000: "THROMBO"
• GS0421: scientific services and research, namely, medical and scientific research in the field of thrombosis, thrombotic risks and diagnosis, scientific research and development, information on the subject of scientific research in the field of biotechnology, medical and scientific research, namely, conducting clinical trials, providing medical and scientific research information in the field of pharmaceuticals and clinical trials, providing reagent sample testing and diagnostic services for others in the field of science; genetic testing for scientific research purposes; providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto

Case File Event Statements

• 4/10/2023 - a year ago

  20 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6

• 4/10/2023 - a year ago

  19 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 9/6/2022 - 2 years ago

  18 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 7/12/2022 - 2 years ago

  17 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 7/12/2022 - 2 years ago

  16 - PUBLISHED FOR OPPOSITION Type: PUBO

• 6/22/2022 - 2 years ago

  15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 6/4/2022 - 2 years ago

  14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 6/3/2022 - 2 years ago

  13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/2/2022 - 2 years ago

  12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 6/2/2022 - 2 years ago

  11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 12/3/2021 - 3 years ago

  10 - NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Type: GEAN

• 12/3/2021 - 3 years ago

  9 - EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Type: GEAP

• 12/3/2021 - 3 years ago

  8 - COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY Type: EPEN

• 12/3/2021 - 3 years ago

  7 - EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED Type: CPEA

• 6/19/2021 - 3 years ago

  6 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN

• 6/19/2021 - 3 years ago

  5 - PRIORITY ACTION E-MAILED Type: GPRA

• 6/19/2021 - 3 years ago

  4 - PRIORITY ACTION WRITTEN Type: CPRA

• 6/11/2021 - 3 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 2/26/2021 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 12/21/2020 - 4 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP